Andre J. Fernandez - 20 May 2026 Form 4/A - Amendment Insider Report for Cardlytics, Inc. (CDLX)

Reporting relationship: Director
Issuer ticker: CDLX
Reported as of: 20 May 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 24 Aug 2026, 16:04:48 UTC
Original report date: 21 May 2026
Prior SEC filing: 30 Jan 2026
Next SEC filing: 29 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Chris Cheng, Attorney-in-Fact

Key filing fact

Andre J. Fernandez filed Form 4/A - Amendment for Cardlytics, Inc. (CDLX) on 24 Aug 2026.

Key facts

This page summarizes Andre J. Fernandez's Form 4/A - Amendment filing for Cardlytics, Inc. (CDLX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Aug 2026, 16:04.

Change

Previous filing in this sequence was filed on 30 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001447718 Primary reporting owner

Fernandez Andre J

Relationship: Director
Address: 675 PONCE DE LEON AVENUE NE, SUITE 4100, ATLANTA
Signature: /s/ Chris Cheng, Attorney-in-Fact
Signature date: 24 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDLX transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +2,200
Change %
Price: $0.000000^*
Shares after: 2,200
Date: 20 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,200
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

Footnote F2

On May 21, 2026, the reporting person filed a Form 4 which inadvertently reported an incorrect number of shares underlying the RSU awarded to the reporting person. As reported in this amendment, the reporting person was awarded RSUs representing a right to receive 2,200 shares of the Issuer's common stock. The number of securities reported within this footnote have been adjusted to reflect the 1-for-10 reverse stock split of the Issuer's common stock, which was effective June 5, 2026.

Footnote F3

The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney